For example, viral gene-therapy vectors or oncolytic viruses have been used to transduce tumour cells with arbitrary foreign antigens or antigens with a known side-effect profile in CAR T cell therapy (such as CD19) (refs. 24,26,27). Here, CD19 is linked to neoplasm.